Cargando…
Differential Cardiovascular Outcomes of Each Antihypertensive Drug Class in Patients With Hypertension and Breast Cancer Undergoing Doxorubicin-Containing Chemotherapy
PURPOSE: The preemptive use of renin-angiotensin system (RAS) inhibitors may reduce doxorubicin (DOX)-related cardiotoxicity. Using the national insurance claims data of Korea, this study compared cardiovascular (CV) outcomes following the use of four major antihypertensive drug classes in patients...
Autores principales: | Hwang, Hui-Jeong, Han, Sang-Ah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Breast Cancer Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625866/ https://www.ncbi.nlm.nih.gov/pubmed/37704380 http://dx.doi.org/10.4048/jbc.2023.26.e34 |
Ejemplares similares
-
Comparison of Antihypertensive Drug Classes for Dementia Prevention
por: Walker, Venexia M., et al.
Publicado: (2020) -
The Effects of Different Classes of Antihypertensive Drugs on Patients with COVID-19 and Hypertension: A Mini-Review
por: Nozari, Farnoosh, et al.
Publicado: (2022) -
Adherence to Antihypertensive Medication in Treatment‐Resistant Hypertension Undergoing Renal Denervation
por: Schmieder, Roland E., et al.
Publicado: (2016) -
Antihypertensive medication class and diastolic orthostatic hypertension in older Caribbean adult patients
por: Smith, Latoya, et al.
Publicado: (2023) -
Receptor complexes for each of the Class 3 Semaphorins
por: Sharma, Anil, et al.
Publicado: (2012)